GlassScriptPhysician profile
Dean R Meisel
NPI 1982716502
$977.76
in general payments reported to CMS, 2019-2025
17 companies · $79.05 in 2025
The $79.05 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $140 · 2021: $22.44 · 2024: $223 · 2025: $79.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $258.58 | 2019-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $138.33 | 2019-2025 | Vaxelis, Capvaxive, Gardasil 9 |
| Insulet Corporation | $125.00 | 2024 | Omnipod |
| Novo Nordisk INC | $118.59 | 2019-2024 | Rybelsus, Ozempic |
| Amgen INC. | $70.30 | 2019-2020 | |
| Glaxosmithkline, LLC. | $60.48 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $30.57 | 2019 | |
| Abbvie INC. | $28.13 | 2024 | |
| Lilly USA, LLC | $26.91 | 2020-2024 | Zepbound, Jardiance |
| Abbott Laboratories | $19.53 | 2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $19.34 | 2024 | Rexulti |
| Antares Pharma, INC. | $17.38 | 2024 | Xyosted |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.61 | 2019 | |
| Ironshore Pharmaceuticals INC. | $14.28 | 2019 | |
| Eisai INC. | $13.43 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $11.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Meisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.